SWOG clinical trial number
SWOG-9446

Chemoprevention Trial to Prevent Second Primary Tumors with Low-Dose 13-Cis Retinoic Acid in Head and Neck Cancer

Closed
Phase
Published
Abbreviated Title
Chemoprevention Trial to Prevent Second Primary Tumors with Low-Dose 13-Cis Retinoic Acid in Head and Neck Cancer
Activated
05/15/1995
Closed
06/30/1999

Publication Information Expand/Collapse

2006

Randomized phase III trial of low-dose isotretinoin for prevention of second primary tumors in stage I and II head and neck cancer patients

FR Khuri;JJ Lee;SM Lippman;ES Kim;JS Cooper;SE Benner;R Winn;TF Pajak;B Williams;G Shenouda;I Hodson;K Fu;DM Shin;EE Vokes;L Feng;H Goepfert;WK Hong Journal of the National Cancer Institute 98(7):441-450

2004

Prognostic factors in early stage head and neck squamous cell carcinoma (HNSCC) patients in a prospective clinical trial

ES Kim;J Lee;L Feng;S Lippman;G Shenouda;I Hodson;E Vokes;F Khuri;WK Hong Proc of the American Society of Clinical Oncology 23:490 (#5515)

2003

Isotretinoin effets on head and neck cancer recurrence and second primary tumors

F Khuri;JJ Lee;S Lippman;ES Kim;JS Cooper;SE Benner;EE Vokes;TF Pajak;H Goepfert;WK Hong Proc of the American Society of Clinical Oncology 22:90 (#359)

Longterm adherence, toxicity, and dose-intensity in a head and neck chemoprevention trial

JJ Lee;ES Kim;FR Khuri;RM Chamberlain;L Feng;B Williams;K Fu;J Cooper;SM Lippman;WK Hong Proc of the American Society of Clinical Oncology 22:91 (#364)